Position in ARGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$430,847
-$239,390 QoQ
Shares Held
590
-26.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MGO ONE SEVEN LLC holds $4,461,228 across 10 Biotechnology names. ARGX ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,265 | $1,457,953 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
100,000 | $696,000 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
649 | $501,443 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
7,348 | $474,901 | |
| 5 | ARGX |
Argenx SE
This page
|
590 | $430,847 | |
| 6 | MDWD |
MediWound Ltd.
|
22,163 | $357,045 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
780 | $258,078 | |
| 8 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
26,817 | $207,027 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $430,847 | 590 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $670,237 | 797 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $427,047 | 579 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $210,014 | 381 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $224,316 | 379 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $322,875 | 525 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $208,856 | 549 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $234,507 | 477 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||